Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation.
Journal: Journal of thrombosis and thrombolysis
Published: April 24, 2020
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism.
Journal: Journal of thrombosis and thrombolysis
Published: April 24, 2020
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism.
Journal: Journal of thrombosis and thrombolysis
Published: April 24, 2020
Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome.
Journal: Therapeutic advances in cardiovascular disease
Published: August 01, 2019
Randomized phase 2 trial comparing JNJ-9375, a thrombin-directed antibody, with apixaban for prevention of venous thrombosis.
Journal: Journal of thrombosis and haemostasis : JTH
Published: June 11, 2019
Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: March 29, 2019
Comment on model-based meta-analysis to evaluate optimal doses of direct oral factor Xa inhibitors in atrial fibrillation patients.
Journal: Blood advances
Published: October 18, 2018
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
Journal: The New England journal of medicine
Published: May 17, 2018
Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: January 02, 2018
A Cross-Study Analysis Evaluating the Effects of Food on the Pharmacokinetics of Rivaroxaban in Clinical Studies.
Journal: Journal of clinical pharmacology
Published: February 15, 2017
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial.
Journal: European stroke journal
Published: June 14, 2016
Last Updated: 09/26/2026